Corona Remedies Ltd’s share price target is a topic of much discussion among investors because the company has become a strong and trusted brand in the Indian pharmaceutical sector. Due to its domestically focused pharma portfolio, consistent revenue growth, and improving margins, the Corona Remedies Ltd share price target looks quite promising for the long term.
With increasing healthcare demand in India, the Corona Remedies Ltd share price target shows good upside potential from 2025 to 2030. The company’s focus on chronic therapies, brand led formulations, and strong doctor connect supports future growth. The current price of Corona Remedies Ltd is ₹1,471.00, and market sentiment remains positive for the company.
Corona Remedies Ltd Share Price Target 2025
The Corona Remedies Ltd share price target could reach the range of ₹1,510 – ₹1,540 by the end of 2025. A gradual upside in the Corona Remedies Ltd share price target is expected in the last months of the year due to prescription growth and festive season demand.
This year, the Corona Remedies Ltd share price target shows stable growth despite the limited time frame, reflecting the company’s strong fundamentals.
| Month | Expected Price (INR) |
|---|---|
| December | ₹1,510 – ₹1,540 |
Corona Remedies Ltd Share Price Target 2026
The Corona Remedies Ltd share price target could reach ₹1,620 – ₹1,700 in 2026. The company is expanding its market share in chronic therapy segments such as cardiology, diabetology, and pain management, which will directly impact the Corona Remedies Ltd share price target.
In 2026, the Corona Remedies Ltd share price target is likely to show steady and healthy growth, backed by a strong brand portfolio and operational efficiency.
| Month | Expected Price (INR) |
|---|---|
| January | ₹1,550 – ₹1,565 |
| February | ₹1,565 – ₹1,580 |
| March | ₹1,580 – ₹1,595 |
| April | ₹1,595 – ₹1,610 |
| May | ₹1,610 – ₹1,625 |
| June | ₹1,625 – ₹1,640 |
| July | ₹1,640 – ₹1,655 |
| August | ₹1,655 – ₹1,670 |
| September | ₹1,670 – ₹1,685 |
| October | ₹1,685 – ₹1,700 |
| November | ₹1,695 – ₹1,720 |
| December | ₹1,710 – ₹1,740 |
ALSO READ: Meesho Ltd Share Price Target 2025, 2026, 2027, 2028, 2029, 2030 | Future Forecast, Monthly Outlook
Corona Remedies Ltd Share Price Target 2027
The Corona Remedies Ltd share price target could remain in the range of ₹1,880 – ₹1,950 in 2027. The company’s product launches and rural market penetration could further strengthen the Corona Remedies Ltd share price target.
This year, the Corona Remedies Ltd share price target will be supported by higher margins, a strong doctor network, and increasing healthcare awareness.
| Month | Expected Price (INR) |
|---|---|
| January | ₹1,750 – ₹1,770 |
| February | ₹1,770 – ₹1,790 |
| March | ₹1,790 – ₹1,810 |
| April | ₹1,810 – ₹1,830 |
| May | ₹1,830 – ₹1,850 |
| June | ₹1,850 – ₹1,870 |
| July | ₹1,870 – ₹1,890 |
| August | ₹1,890 – ₹1,910 |
| September | ₹1,910 – ₹1,930 |
| October | ₹1,930 – ₹1,955 |
| November | ₹1,945 – ₹1,970 |
| December | ₹1,960 – ₹1,990 |
Corona Remedies Ltd Share Price Target 2028
The Corona Remedies Ltd share price target could reach ₹2,120 – ₹2,200 in 2028. The prevalence of chronic diseases and the demand for branded generics will support the Corona Remedies Ltd share price target in the long term.
The company’s scale up and distribution reach this year could take the Corona Remedies Ltd share price target to the next level.
| Month | Expected Price (INR) |
|---|---|
| January | ₹2,000 – ₹2,020 |
| February | ₹2,020 – ₹2,040 |
| March | ₹2,040 – ₹2,060 |
| April | ₹2,060 – ₹2,080 |
| May | ₹2,080 – ₹2,100 |
| June | ₹2,100 – ₹2,120 |
| July | ₹2,120 – ₹2,140 |
| August | ₹2,140 – ₹2,160 |
| September | ₹2,160 – ₹2,180 |
| October | ₹2,180 – ₹2,200 |
| November | ₹2,190 – ₹2,220 |
| December | ₹2,210 – ₹2,240 |
Corona Remedies Ltd Share Price Target 2029
The Corona Remedies Ltd share price target could trade between ₹2,350 – ₹2,450 in 2029. Strong cash flows and improving return ratios could make the Corona Remedies Ltd share price target even more attractive.
For long-term investors, the Corona Remedies Ltd share price target in 2029 represents a stable and compounding opportunity.
| Month | Expected Price (INR) |
|---|---|
| January | ₹2,250 – ₹2,270 |
| February | ₹2,270 – ₹2,290 |
| March | ₹2,290 – ₹2,310 |
| April | ₹2,310 – ₹2,330 |
| May | ₹2,330 – ₹2,350 |
| June | ₹2,350 – ₹2,370 |
| July | ₹2,370 – ₹2,390 |
| August | ₹2,390 – ₹2,410 |
| September | ₹2,410 – ₹2,430 |
| October | ₹2,430 – ₹2,450 |
| November | ₹2,440 – ₹2,470 |
| December | ₹2,460 – ₹2,500 |
Corona Remedies Ltd Share Price Target 2030
The Corona Remedies Ltd share price target could reach the range of ₹2,600 – ₹2,700 by 2030. By 2030, the company could become a strong player in the Indian pharma space with its brand strength, prescription dominance, and operational scale.
In the long-term horizon, the Corona Remedies Ltd share price target represents a stable and defensive investment story.
| Month | Expected Price (INR) |
|---|---|
| January | ₹2,520 – ₹2,540 |
| February | ₹2,540 – ₹2,560 |
| March | ₹2,560 – ₹2,580 |
| April | ₹2,580 – ₹2,600 |
| May | ₹2,600 – ₹2,620 |
| June | ₹2,620 – ₹2,640 |
| July | ₹2,640 – ₹2,660 |
| August | ₹2,660 – ₹2,680 |
| September | ₹2,680 – ₹2,700 |
| October | ₹2,700 – ₹2,720 |
| November | ₹2,720 – ₹2,740 |
| December | ₹2,740 – ₹2,770 |
Conclusion
Overall, the Corona Remedies Ltd share price target shows a strong long-term growth story. The potential from the current price of ₹1,471 to over ₹2,700 is based on the company’s strong fundamentals, branded portfolio, and long term tailwinds in the healthcare sector. If you are looking for a stable pharma stock for the long term, the Corona Remedies Ltd share price target could be a good option for your portfolio.
FAQs on Corona Remedies Ltd Share Price Target
Q1. What is the current price of Corona Remedies Ltd?
The current price of Corona Remedies Ltd is ₹1,471.00.
Q2. What could be the Corona Remedies Ltd share price target in 2026?
The Corona Remedies Ltd share price target could be ₹1,620 – ₹1,700 by the end of 2026.
Q3. What will be the Corona Remedies Ltd share price target in 2028?
The Corona Remedies Ltd share price target in 2028 could be in the range of ₹2,120 – ₹2,200.
Q4. How high can the Corona Remedies Ltd share price target go by 2030?
By 2030, the Corona Remedies Ltd share price target could reach the range of ₹2,600 – ₹2,700.
Q5. Is Corona Remedies Ltd a good stock for long-term investment?
Considering the company’s strong brands, stable cash flows, and growth in the pharma sector, Corona Remedies Ltd could be a stable option for long term investors.
Disclaimer
This Corona Remedies Ltd share price target is for educational and forecasting purposes only. Do not consider this as investment advice. Before investing in the stock market, please do your own research or consult a financial advisor.
A stock market enthusiast with hands-on experience in trading. He writes simple and practical content to help people understand the market better.